This inventor holds 1 USPTO granted patent. Top assignee: Neurovance, Inc.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Richard Welter: Innovator in Therapeutic Methods
Introduction
Richard Welter is a notable inventor based in Las Cruces, NM (US). He has made significant contributions to the field of medicine, particularly in developing novel therapeutic methods for various disorders. His work focuses on addressing fragile X associated disorders, ADHD, and autism spectrum disorder.
Latest Patents
Richard Welter holds a patent for "Methods of treating fragile X associated disorders, ADHD, and autism spectrum disorder." This patent outlines innovative methods that involve administering a therapeutically effective amount of (1R,5S)-1-(naphthalen-2-yl)-3-azabicyclo[3.1.0]hexane, in free or pharmaceutically acceptable salt form, to patients in need of treatment. This patent represents a significant advancement in therapeutic approaches for these conditions.
Career Highlights
Welter's career is marked by his dedication to research and innovation in the medical field. He has been instrumental in developing methods that can potentially improve the quality of life for individuals affected by these disorders. His work at Neurovance, Inc. showcases his commitment to advancing therapeutic solutions.
Collaborations
Richard Welter has collaborated with notable colleagues, including Anthony Alexander McKinney and Franklin Bymaster. These partnerships have contributed to the development and refinement of his innovative methods.
Conclusion
In summary, Richard Welter is a distinguished inventor whose work in therapeutic methods has the potential to make a significant impact on the treatment of fragile X associated disorders, ADHD, and autism spectrum disorder. His contributions to the field are commendable and reflect his dedication to improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile